National Bank of Canada’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67K | Sell |
98
-312
| -76% | -$5.33K | ﹤0.01% | 2277 |
|
|
2025
Q1 | $26.2K | Sell |
410
-5
| -1% | -$319 | ﹤0.01% | 1720 |
|
|
2024
Q4 | $50.5K | Buy |
415
+28
| +7% | +$3.41K | ﹤0.01% | 1596 |
|
|
2024
Q3 | $48.3K | Sell |
387
-7,140
| -95% | -$892K | ﹤0.01% | 1537 |
|
|
2024
Q2 | $1.18M | Buy |
7,527
+369
| +5% | +$57.8K | ﹤0.01% | 918 |
|
|
2024
Q1 | $944K | Sell |
7,158
-4,835
| -40% | -$637K | ﹤0.01% | 989 |
|
|
2023
Q4 | $1.15M | Buy |
11,993
+4,500
| +60% | +$433K | ﹤0.01% | 978 |
|
|
2023
Q3 | $889K | Sell |
7,493
-12,156
| -62% | -$1.44M | ﹤0.01% | 1047 |
|
|
2023
Q2 | $2.23M | Buy |
19,649
+10,526
| +115% | +$1.19M | ﹤0.01% | 862 |
|
|
2023
Q1 | $1.26M | Sell |
9,123
-291,357
| -97% | -$40.1M | ﹤0.01% | 886 |
|
|
2022
Q4 | $38.9M | Buy |
300,480
+300,322
| +190,077% | +$38.9M | 0.1% | 162 |
|
|
2022
Q3 | $17K | Hold |
158
| – | – | ﹤0.01% | 1890 |
|
|
2022
Q2 | $12K | Hold |
158
| – | – | ﹤0.01% | 2015 |
|
|
2022
Q1 | $12K | Hold |
158
| – | – | ﹤0.01% | 2091 |
|
|
2021
Q4 | $14K | Buy |
+158
| New | +$14K | ﹤0.01% | 2033 |
|